Literature DB >> 19022006

Usefulness of osteosynthesis device made of hydroxyapatite-poly-L-lactide composites in port-access cardiac surgery.

Tsutomu Ito1, Mikihiko Kudo, Ryohei Yozu.   

Abstract

BACKGROUND: Port-access minimally invasive cardiac surgery has been developed with the aim of reducing surgical invasion. We conduct port-access cardiac surgery, generally through an intercostal space. To ensure sufficient visual field, either the upper or lower rib may be divided. In the process of restoration of divided ribs, we have developed a bone fixation technique using a new osteosynthesis device by way of prevention of pseudoarthrosis.
METHODS: Forty-five consecutive patients underwent right-sided anterior intercostal thoracotomy under the port-access method between July 2006 and July 2007. We used a totally resorbable osteosynthesis device (Super Fixsorb; Takiron Co., Ltd., Osaka, Japan) consisting of a mix of poly-L-lactide (PLLA) and particulate resorbable uncalcined hydroxyapatite (u-HA).
RESULTS: Fixation of the rib-costal cartilage was sufficiently achieved in this manner. No clinical symptoms suggestive of inflammation or infection were identified in the areas corresponding to the site of bone junction, and no patients have suffered pseudoarthrosis perioperatively and up to one year after surgery. Computed tomographic (CT) scanning clearly visualized these devices, and their attachment to the rib surfaces was confirmed in the patient who underwent CT scanning after the longest tested interval of 133 days after surgery.
CONCLUSIONS: In this study, the possibility was suggested that the advantages of u-HA/PLLA composite, such as early osteoconductive property and bioactive property, might beneficially affect bone fusion. We conclude that this osteosynthesis device can be applied in various fields, including cardiovascular surgery, and that its use will contribute to improvement of patients' postoperative quality of life.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022006     DOI: 10.1016/j.athoracsur.2008.08.059

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  A bioresorbable osteosynthesis device can induce an earlier sternal fusion after median sternotomy.

Authors:  Tomohiro Tsunekawa; Akihiko Usui; Hideki Oshima; Shinnichi Mizutani; Yoshimori Araki; Noritaka Okada; Yuichi Ueda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-23

2.  Clinical application of a custom-made bioresorbable raw particulate hydroxyapatite/poly-L-lactide mesh tray for mandibular reconstruction.

Authors:  Akira Matsuo; Hiroshige Chiba; Hidetoshi Takahashi; Jun Toyoda; Harutsugi Abukawa
Journal:  Odontology       Date:  2010-02-16       Impact factor: 2.634

3.  Sternal semi-closure using a bioresorbable osteosynthesis device: a new method for delayed sternal closure.

Authors:  Yuki Tanaka; Takashi Miyamoto; Yuji Naito; Shuichi Yoshitake; Akihiro Sasahara; Kagami Miyaji
Journal:  Surg Today       Date:  2018-03-16       Impact factor: 2.549

4.  Usefulness of sternal closure with bioresorbable plate in respiratory function after coronary artery bypass grafting.

Authors:  Kiyoshi Tamura; Toshiyuki Maruyama; Syogo Sakurai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-09-11

5.  Successful Surgical Fixation Using Bio-Absorbable Plates for Frail Chest in a Severe Osteoporotic Octogenarian.

Authors:  Ryuichi Waseda; Isao Matsumoto; Yasuhiko Tatsuzawa; Akinori Iwasaki
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-03-22       Impact factor: 1.520

6.  Induced osteogenesis using biodegradable and titanium periosteal distractors.

Authors:  Marwa Madi
Journal:  Saudi Dent J       Date:  2020-12-31

7.  Clinical assessment of efficacy of poly-L-lactide sternal pin on sternal stability and post-operative pain: a prospective randomized trial in cardiovascular surgery.

Authors:  Shingo Takahara; Konosuke Sasaki; Takeshi Saito; Kei Sakuma; Hidenori Fujiwara; Ichiro Yoshioka; Kiichiro Kumagai; Wenyu Sun; Kei Takase; Yoshikatsu Saiki
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.